These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31944282)

  • 21. Use of cell block preparation for morphological, immunocytochemistry, and ploidy analysis in ThinPrep monolayer preparations.
    Freitas C; Milanezi F; Dias AJ; Bento MJ; Schmitt FC
    Diagn Cytopathol; 2001 Dec; 25(6):415-7. PubMed ID: 11747241
    [No Abstract]   [Full Text] [Related]  

  • 22. Randomised study of HPV prevalence and detection of CIN2+ in vaginal self-sampling compared to cervical specimens collected by medical personnel.
    Gustavsson I; Aarnio R; Berggrund M; Hedlund-Lindberg J; Sanner K; Wikström I; Enroth S; Olovsson M; Gyllensten U
    Int J Cancer; 2019 Jan; 144(1):89-97. PubMed ID: 29943822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus detection to screen for cervical cancer.
    Moselhi M
    JAMA; 2000 Jul; 284(1):39-40. PubMed ID: 10872003
    [No Abstract]   [Full Text] [Related]  

  • 24. Testing for human papillomavirus in women with abnormal pap smear results.
    Sawaya GF; Smith-McCune K
    JAMA; 2002 Sep; 288(11):1350-1; author reply 1351-2. PubMed ID: 12234220
    [No Abstract]   [Full Text] [Related]  

  • 25. Testing for human papillomavirus in women with abnormal pap smear results.
    McCaffery KJ; Waller J; Forrest S; Wardle J
    JAMA; 2002 Sep; 288(11):1350; author reply 1351-2. PubMed ID: 12234219
    [No Abstract]   [Full Text] [Related]  

  • 26. Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study.
    Bertucci M; Bonnet E; Satger L; Kreiche A; Chappert JL; Loy-Morel S; Segondy M; Daurès JP; Boulle N
    Women Health; 2021 Jan; 61(1):83-94. PubMed ID: 33106125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cervical cancer screening: restoration or reconstruction?].
    Riethmuller D
    Gynecol Obstet Fertil; 2009; 37(7-8):671-9. PubMed ID: 19577501
    [No Abstract]   [Full Text] [Related]  

  • 28. Cervical cancer screening.
    Burns R
    Cleve Clin J Med; 2005 Apr; 72(4):272; author reply 272. PubMed ID: 15850238
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.
    Bansal M; Zhao C
    J Low Genit Tract Dis; 2011 Apr; 15(2):105-9. PubMed ID: 21317806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there a role for human papillomavirus testing in clinical practice?
    Kaufman RH
    Obstet Gynecol; 2001 Nov; 98(5 Pt 1):724-5. PubMed ID: 11704159
    [No Abstract]   [Full Text] [Related]  

  • 31. Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology.
    Belinson JL; Qiao YL; Pretorius RG; Zhang WH; Rong SD; Huang MN; Zhao FH; Wu LY; Ren SD; Huang RD; Washington MF; Pan QJ; Li L; Fife D
    Int J Gynecol Cancer; 2003; 13(6):819-26. PubMed ID: 14675319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history of cervical human papillomavirus.
    Cuzick J; Sasieni P
    Lancet; 2001 Nov; 358(9292):1550-1; author reply 1551-2. PubMed ID: 11705600
    [No Abstract]   [Full Text] [Related]  

  • 33. The Impact and Burden of Human Papillomavirus-Associated Disease.
    Ducatman BS
    Arch Pathol Lab Med; 2018 Jun; 142(6):686-687. PubMed ID: 29848033
    [No Abstract]   [Full Text] [Related]  

  • 34. Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network Across Rural Greece: The GRECOSELF Study.
    Agorastos T; Chatzistamatiou K; Tsertanidou A; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moysiadis T; Moschaki V; Skenderi A; Katsiki E; Aggelidou S; Venizelos I; Ntoula M; Daponte A; Vanakara P; Garas A; Stefos T; Vrekoussis T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Manidakis G; Deligeoroglou E; Panoskaltsis T; Decavalas GO; Michail G; Kalogiannidis I; Koukoulis G; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Chronopoulou A; Vaitsi V; Chatzaki E; Paschopoulos M; Adonakis G; Kaufmann AM; Hadzidimitriou A; Stamatopoulos K
    Cancer Prev Res (Phila); 2019 Oct; 12(10):701-710. PubMed ID: 31427275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France.
    Sancho-Garnier H; Tamalet C; Halfon P; Leandri FX; Le Retraite L; Djoufelkit K; Heid P; Davies P; Piana L
    Int J Cancer; 2013 Dec; 133(11):2681-7. PubMed ID: 23712523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study.
    El-Zein M; Bouten S; Louvanto K; Gilbert L; Gotlieb W; Hemmings R; Behr MA; Franco EL;
    Gynecol Oncol; 2018 Jun; 149(3):491-497. PubMed ID: 29678360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison Study of Self-Sampled and Physician-Sampled Specimens for High-Risk Human Papillomavirus Test and Cytology.
    Satake H; Inaba N; Kanno K; Mihara M; Takagi Y; Kondo N; Sagae S
    Acta Cytol; 2020; 64(5):433-441. PubMed ID: 32396902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
    Flores Y; Shah K; Lazcano E; Hernández M; Bishai D; Ferris DG; Lörincz A; Hernández P; Salmerón J;
    Salud Publica Mex; 2002; 44(4):335-44. PubMed ID: 12216521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can self vaginal douching for high risk HPV screening replace or assist efficacy of cervical cancer screening?
    Suwannarurk K; Bhamarapravatana K; Kheolamai P; Thaweekul Y; Mairaing K; Poomtavorn Y; Pattaraarchachai J
    Asian Pac J Cancer Prev; 2010; 11(5):1397-401. PubMed ID: 21198300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing.
    Sanner K; Wikström I; Strand A; Lindell M; Wilander E
    Br J Cancer; 2009 Sep; 101(5):871-4. PubMed ID: 19654577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.